Aerie Pharmaceuticals (AERI) was downgraded at Cantor Fitzgerald to hold from buy. Twelve-month price target is $12. On April 23, Aerie management reported disappointing efficacy results from the first Phase III trial for Rhopressa, the company's lead glaucoma candidate, Cantor Fitzgerald said.
Amazon.com (AMZN - Get Report) was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $535. Analysts are upgrading on accelerating growth, improving profitability and Amazon Web Services valuation, J.P. Morgan said.
AT&T (T) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: T Ratings Report.
BB&T (BBT) was downgraded at Compass Point to neutral from buy. Twelve-month price target is $39. Company is lacking growth and facing net interest margin pressure, Compass Point said.
Best Buy (BBY - Get Report) was downgraded to neutral from overweight at J.P. Morgan. Twelve-month price target is $40. Analysts believe a slow start to the year for sales is likely to raise uncertainty on lapping stronger sales in the back half (that were driven by the TV inflection, significance of the new iPhone, and mass adoption of wearables), and this is likely to keep a lid on the stock's valuation until there is greater clarity given that the company's fourth quarter is 57% of earnings, J.P. Morgan said.
Capital One (COF - Get Report) was downgraded at FBR Capital Markets to market perform from outperform. Twelve-month price target is $87. Company is facing higher costs and slower consumer and commercial loan growth, FBR Capital Markets said.
EMC (EMC) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: EMC Ratings Report.
Juniper (JNPR - Get Report) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $29. Sales appear to have stabilized and there are early signs of higher telecom spending, RBC Capital said.
Mattel (MAT) was upgraded at Goldman Sachs to buy. Twelve-month price target is $37. New management is making the right strategic changes, Goldman Sachs said.
Manitowoc (MTW) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $20. Company is facing challenges in its food service and crane businesses, RBC Capital said.
Microsoft (MSFT - Get Report) was upgraded at Nomura to buy from neutral. Unchanged $50 price target. Microsoft will begin to show low single-digit revenue growth on an organic constant currency basis in calendar 2016, with about 10% EPS growth from the leverage of share repurchases and a 2.9% dividend yield, at a reasonable valuation of 12.4 times tax-effected EV/uFCF on Nomura's 2016 estimates, Nomura said.
Omnicare (OCR) was downgraded at RBC Capital to sector perform from outperform. Valuation call, based on an $82 price target.
Quintiles (Q) was upgraded at Jefferies to buy from hold. Twelve-month price target is $79. Q is coming off a year of solid top-line growth but even stronger bookings growth, Jefferies said.
No comments:
Post a Comment